Incivek Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
Condition: Hepatitis C VirusInterventions: Biological: Peginterferon Lambda-1a; Biological: Peginterferon Alfa-2a; Drug: Ribavirin; Drug: TelaprevirSponsor: Bristol-Myers SquibbActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2012 Category: Research Source Type: clinical trials

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Condition: Hepatitis CInterventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin; Drug: telaprevirSponsor: University of ChicagoTerminated - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2012 Category: Research Source Type: clinical trials

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Condition: Hepatitis CInterventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin; Drug: telaprevirSponsor: University of ChicagoTerminated - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2012 Category: Research Source Type: clinical trials